Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 2
1991 2
1992 2
1993 2
1994 3
1996 1
1997 1
1999 1
2002 2
2005 1
2006 1
2007 2
2008 3
2009 4
2011 1
2012 3
2013 3
2014 1
2015 3
2016 4
2017 1
2018 1
2020 1
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

42 results
Results by year
Filters applied: . Clear all
Page 1
Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial.
Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, Zwinderman AH, Ronday HK, Han KH, Westedt ML, Gerards AH, van Groenendael JH, Lems WF, van Krugten MV, Breedveld FC, Dijkmans BA. Goekoop-Ruiterman YP, et al. Among authors: van zeben d. Arthritis Rheum. 2005 Nov;52(11):3381-90. doi: 10.1002/art.21405. Arthritis Rheum. 2005. PMID: 16258899 Free article. Clinical Trial.
Cardiovascular risk in rheumatoid arthritis: how to lower the risk?
van Breukelen-van der Stoep DF, Klop B, van Zeben D, Hazes JM, Castro Cabezas M. van Breukelen-van der Stoep DF, et al. Among authors: van zeben d. Atherosclerosis. 2013 Nov;231(1):163-72. doi: 10.1016/j.atherosclerosis.2013.09.006. Epub 2013 Sep 20. Atherosclerosis. 2013. PMID: 24125429 Review.
Adherence to cardiovascular prevention strategies in patients with rheumatoid arthritis.
van Breukelen-van der Stoep DF, Zijlmans J, van Zeben D, Klop B, van de Geijn GJ, van der Meulen N, Hazes M, Birnie E, Castro Cabezas M. van Breukelen-van der Stoep DF, et al. Among authors: van zeben d. Scand J Rheumatol. 2015;44(6):443-8. doi: 10.3109/03009742.2015.1028997. Epub 2015 Jul 14. Scand J Rheumatol. 2015. PMID: 26169960
Marked underdiagnosis and undertreatment of hypertension and hypercholesterolaemia in rheumatoid arthritis.
van Breukelen-van der Stoep DF, van Zeben D, Klop B, van de Geijn GJ, Janssen HJ, van der Meulen N, De Vries MA, Hazes M, Birnie E, Castro Cabezas M. van Breukelen-van der Stoep DF, et al. Among authors: van zeben d. Rheumatology (Oxford). 2016 Jul;55(7):1210-6. doi: 10.1093/rheumatology/kew039. Epub 2016 Mar 23. Rheumatology (Oxford). 2016. PMID: 27009825
Effects of psychosocial factors on monitoring treatment effect in newly diagnosed rheumatoid arthritis patients over time: response data from the tREACH study.
Kuijper TM, Luime JJ, Xiong H, de Jong P, van der Lubbe P, van Zeben D, Tchetverikov I, Hazes J, Weel A. Kuijper TM, et al. Among authors: van zeben d. Scand J Rheumatol. 2018 May;47(3):178-184. doi: 10.1080/03009742.2017.1349176. Epub 2017 Oct 2. Scand J Rheumatol. 2018. PMID: 28967272 Clinical Trial.
Tapering conventional synthetic DMARDs in patients with early arthritis in sustained remission: 2-year follow-up of the tREACH trial.
Kuijper TM, Luime JJ, de Jong PH, Gerards AH, van Zeben D, Tchetverikov I, de Sonnaville PB, van Krugten MV, Grillet BA, Hazes JM, Weel AE. Kuijper TM, et al. Among authors: van zeben d. Ann Rheum Dis. 2016 Dec;75(12):2119-2123. doi: 10.1136/annrheumdis-2016-209272. Epub 2016 Jun 9. Ann Rheum Dis. 2016. PMID: 27283332 Clinical Trial.
Best cost-effectiveness and worker productivity with initial triple DMARD therapy compared with methotrexate monotherapy in early rheumatoid arthritis: cost-utility analysis of the tREACH trial.
de Jong PH, Hazes JM, Buisman LR, Barendregt PJ, van Zeben D, van der Lubbe PA, Gerards AH, de Jager MH, de Sonnaville PB, Grillet BA, Luime JJ, Weel AE. de Jong PH, et al. Among authors: van zeben d. Rheumatology (Oxford). 2016 Dec;55(12):2138-2147. doi: 10.1093/rheumatology/kew321. Epub 2016 Aug 30. Rheumatology (Oxford). 2016. PMID: 27581208 Clinical Trial.
42 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page